Gerresheimer, a leading global manufacturer of primary packaging for the pharmaceutical industry is presenting its new Gx RTF vials product offering. They accompany the product from clinical test to industrial filling because they are already depyrogenated, sterile and therefore ready for use. Gerresheimer offers both its own packaging, as well as the familiar SG EZ-fill packaging design.

Gx RTF vials – ready for filling

The Gx RTF injection vials are made from type I borosilicate glass and meet all current requirements of the applicable ISO standards and pharmacopeias (USP and Ph. Eur.). They are manufactured in accordance with cGMP, washed in a cleanroom, packed in trays or in nests and tub and finally sterilized. Gerresheimer offers its own packaging as well as the well-known SG EZ-fill packaging design. This means the vials are ready for the next steps in the filling process without any further and/or additional handling. The benefits are obvious: sterile delivery, a simplified fill and finish process, the highest quality standards, flexibility thanks to various possible packaging options and a wide range of filling and sealing technologies. These all lead to a significant reduction on overall manufacturing costs across the product’s entire lifecycle and improve patient safety.

Flexibility through various packaging configurations and global operational footprint

The range for RTF vials includes various end-of-line packaging solutions. These new packaging formats allow customers to use RTF vials to support their operations in all phases of drug and new drug product development, as well as in small or large commercial production. SG EZ-fill Nest & Tub packaging products offering 2R, 6R and 10R vial formats are special tray packaging formats that support all tubular glass products from 2ml to 30ml (clear and amber). Additional packaging solutions are currently being developed to support molded glass products ranging in size from 5ml to 50ml (clear and amber).

Highest quality requirements

Gx RTF injection vials meet all specified requirements of applicable ISO standards and pharmacopoeias (USP and Ph. Eur.). They are offered in Gx Elite, Gx Armor and Gx Pharma Plus quality formats to meet or exceed customer or industry quality requirements. RTF packaging solutions offered with SG EZ-fill packaging platforms further improve end-product quality by avoiding glass-to-glass contact, which can lead to glass breakage and the development of cosmetic defects.

Gerresheimer injection vials according to international standards

Injection vials are the standard for primary packaging for parenteral medicines. Gerresheimer RTF vials are available in many sizes. They meet and exceed all international standards and pharmacopoeia requirements. The range of applications includes customized solutions for high-quality products for combination medical devices, biotechnologically produced medicines, and branded products as well as other specialized pharmaceutical applications.

Gerresheimer’s global production sites manufacture and supply for individual and specific market requirements, which has a positive impact on the customer’s total cost of ownership.

Gerresheimer at CPhI Worldwide in Milano

Gerresheimer presents its sustainable innovations and solutions from November 09 to 11 at CPhI Worldwide in Milano, Fiera Milano, Hall 6 at Booth 6J10.

RTF vials – Gerresheimer AG

Gx® and RTF® are registered trademarks of the Gerresheimer Group. SG EZ-fill® is a registered trademark of the Stevanato Group.

Über die Gerresheimer AG

Gerresheimer is the global partner for pharma, biotech, healthcare and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging and drug delivery devices. The company is an innovative solution provider from concept to delivery of the end product. Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence, focus on quality and customers. In developing innovative and sustainable solutions, Gerresheimer relies on a comprehensive international network with numerous innovation and production centers in Europe, America and Asia. Gerresheimer produces close to its customers worldwide with around 10,000 employees and generates annual sales of more than €1.4 billion. With its products and solutions, Gerresheimer plays an essential role in people’s health and well-being.

Firmenkontakt und Herausgeber der Meldung:

Gerresheimer AG
Klaus-Bungert-Straße 4
40468 Düsseldorf
Telefon: +49 (211) 6181-00
Telefax: +49 (211) 6181-295
http://www.gerresheimer.de

Ansprechpartner:
Jens Kürten
Leiter Corporate Communication und Marketing
Telefon: +49 (211) 6181-250
Fax: +49 (211) 6181-241
E-Mail: J.Kuerten@gerresheimer.com
Marion Stolzenwald
Senior Manager Corporate Communication
Telefon: +49 (211) 6181-246
Fax: +49 (211) 6181-28246
E-Mail: m.stolzenwald@gerresheimer.com
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel